查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1404789

全球給藥裝置市場：規模、佔有率和趨勢分析報告 - 按應用、給藥途徑、最終用途、地區、細分市場預測，2024-2030 年

Drug Delivery Devices Market Size, Share & Trends Analysis Report By Application (Oncology, Infectious Diseases), By Route Of Administration (Oral, Transdermal, Injectable), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 140 Pages | 商品交期: 2-10個工作天內

價格

給藥裝置市場成長與趨勢：

預計2030年，全球給藥裝置市場規模將達4,036億美元，預測期內複合年成長率為5.83%。

癌症、神經系統疾病、糖尿病和其他感染疾病的日益普及預計將在未來幾年推動藥物輸送設備的採用。增加眼科、神經病學和腫瘤學等各種應用的產品推出也有望推動市場成長。居家醫療環境中擴大採用穿戴式藥物輸送設備也有望推動市場發展。

水凝膠是重要的藥物傳遞載體之一，包括超分子水凝膠、DNA水凝膠、仿生水凝膠、多功能水凝膠、刺激反應水凝膠等。這些先進的水凝膠可用於多種應用，包括眼科、口腔、腸道、心臟疾病和癌症應用。同樣，脂質體、奈米粒子和膠束等其他載體也正在開發用於各種應用。

市場上的主要公司正在採取各種策略，例如併購、聯盟和聯合研究，來開發和改進各種應用的藥物傳輸裝置。此外，最終用戶還與公司合作以獲得用於培訓和研究目的的藥物傳輸設備。此外，市場參與者正在簽訂分銷商協議，以擴大其產品的覆蓋範圍。因此，預計每家公司的聯盟將在預測期內推動市場成長。

藥物輸送設備市場報告亮點：

  • 口服給藥途徑細分市場在 2023 年佔據最大佔有率，主要是因為其易於使用且成本低。
  • 在預測期內，注射給藥途徑預計將出現最快的成長，這主要是由於注射給藥設備的不斷進步以提高準確性。
  • 用於中樞神經系統疾病的藥物輸送裝置預計將在預測期內快速成長，這主要是由於用於治療神經系統疾病的血腦障壁藥物輸送裝置的開發取得了進展。
  • 2023年，由於該地區藥物輸送設備的採用增加以及美國等國家產品的推出，北美地區佔據了全球最大的收益佔有率。
  • 由於藥物輸送設備的高度發展和進步以及龐大的患者群體，預計亞太地區在預測期內將出現最快的成長率。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章給藥裝置市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 普及和成長的前景圖
  • 產業價值鏈分析
    • 贖回框架
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
    • 產業挑戰
  • 給藥裝置市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • 主要交易及策略聯盟分析
    • 打入市場策略

第4章給藥途徑（RoA）的估算與趨勢分析

  • 定義和範圍
    • 口服
    • 吸入
    • 經皮的
    • 注射
    • 眼睛
    • 鼻腔
    • 局部的
    • 其他
  • 投資報酬率市場佔有率，2024/2030
  • 細分儀表板
  • 全球給藥裝置市場：RoA 展望
  • 2018-2030 年市場規模、預測與趨勢分析如下
    • 口服
    • 吸入
    • 經皮的
    • 注射
    • 眼睛
    • 鼻腔
    • 局部的
    • 其他

第5章 使用估算/趨勢分析

  • 定義和範圍
    • 腫瘤學
    • 感染疾病
    • 呼吸系統疾病
    • 糖尿病
    • 循環系統疾病
    • 自體免疫疾病
    • 中樞神經系統疾病
    • 其他
  • 應用市場佔有率，2024/2030
  • 細分儀表板
  • 全球給藥裝置市場：按應用分類的前景
  • 2018-2030 年市場規模、預測與趨勢分析如下
    • 腫瘤學
    • 感染疾病
    • 呼吸系統疾病
    • 糖尿病
    • 心血管疾病
    • 自體免疫疾病
    • 中樞神經系統疾病
    • 其他

第6章 最終用途估算及趨勢分析

  • 定義和範圍
    • 醫院
    • 診斷中心
    • 門診手術中心/診所
    • 居家照護設置
    • 其他
  • 最終用途市場佔有率，2023/2030
  • 細分儀表板
  • 全球給藥裝置市場：依最終用途分類的前景
  • 2018-2030 年市場規模、預測與趨勢分析如下
    • 醫院
    • 診斷中心
    • 門診手術中心/診所
    • 居家照護設置
    • 其他

第7章給藥裝置市場：區域估計與趨勢分析

  • 2023/2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概況
  • 2019年區域市場佔有率和主要企業
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東/非洲
  • 依因素（政治/法律、經濟/技術）進行 SWOT 分析
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東/非洲
  • 市場規模/預測、數量/趨勢分析，2018-2030
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭分類
    • 創新者
    • 市場貸款人
    • 新興企業
  • 供應商形勢
    • List of key distributors and channel partners
    • Key customers
    • Key company market share analysis, 2023
  • 上市公司
  • 民營企業
  • 供應商排名
  • 主要企業簡介
    • Pfizer, Inc,
    • F. Hoffmann-La Roche Ltd.
    • Johnson and Johnson Services
    • Novartis AG
    • Bayer AG
    • BD
    • Uniqure NV
    • SiBiono GeneTech Co.
    • Shanghai Sunway Biotech Co., Ltd
    • Human Stem Cells Institute
Product Code: GVR-4-68038-435-2

Drug Delivery Devices Market Growth & Trends:

The global drug delivery devices market size is expected to reach USD 403.6 billion by 2030, registering a CAGR of 5.83% during the forecast period, according to a new report by Grand View Research, Inc. Growing prevalence of cancer, neurological disorders, diabetes, and other infectious diseases is expected to drive the adoption of drug delivery devices in the coming years. In addition, increasing product launches for various applications such as ophthalmology, neurology, and oncology are also expected to propel the market growth. Growing adoption of wearable drug delivery devices for its usage in home-care settings is also expected to drive the market.

Hydrogel is one of the prominent drug delivery vehicles and includes supramolecular hydrogels, DNA hydrogels, bio-inspired hydrogels, multi-functional and stimuli-responsive hydrogels. These advanced hydrogels are used for various applications such as ophthalmic, oral, intestinal, cardiac illness, and cancer. Similarly, other vehicles such as liposomes, nanoparticles, and micelle are also being developed for various applications.

Key players present in the market are adopting various strategies such as mergers and acquisitions, partnership, and collaborations to develop and improve drug delivery devices for various applications. Moreover, end-users are also forming partnerships with companies to acquire drug delivery devices for training purpose and research studies. In addition, market players are also forming distribution agreement to expand the reach of their products. Therefore, alliances made by the players are expected to drive the market growth during the forecast period.

Drug Delivery Devices Market Report Highlights:

  • The oral route of administration segment held largest share in 2023 mainly due to its easy usage and low cost
  • The injectable route of administration segment is expected to experience the fastest growth during the forecast period mainly due to growing advancements in injectable devices for accuracy
  • Drug delivery devices for central nervous system disorders are expected to experience fastest growth rate mainly due to growing development of blood brain barrier drug delivery devices for the treatment of neurological disorders
  • In 2023, North America dominated the global space with the largest revenue share owing to the adoption of drug delivery devices in the region and increasing product launches in the countries such as U.S.
  • Asia Pacific is expected to grow at fastest growth rate during the forecast period mainly due to growing development and advancement in drug delivery devices in the region and presence of large patient pool.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Route of admission (RoA)
    • 1.1.2. Application
    • 1.1.3. End-use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interview in North America
      • 1.3.5.2. Data for primary interview in Europe
      • 1.3.5.3. Data for primary interview in Asia Pacific
      • 1.3.5.4. Data for primary interview in Latin America
      • 1.3.5.5. Data for primary interview in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Route of administration (RoA) outlook
    • 2.2.2. Application outlook
    • 2.2.3. End-use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Drug Delivery Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market driver analysis
      • 3.4.1.1. Growing demand for novel drug delivery devices
      • 3.4.1.2. Increasing prevalence of chronic diseases
      • 3.4.1.3. Technological advancement in drug delivery devices
      • 3.4.1.4. Growing strategic alliances for drug delivery devices
    • 3.4.2. Market restraint analysis
      • 3.4.2.1. Challenges associated with various routes of drug delivery devices
    • 3.4.3. Industry challenges
  • 3.5. Drug Delivery Devices Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape
    • 3.5.3. Major Deals & Strategic Alliances Analysis
    • 3.5.4. Market Entry Strategies

Chapter 4. Route of Administration (RoA) Estimates & Trend Analysis

  • 4.1. Definition and Scope
    • 4.1.1. Oral
    • 4.1.2. Inhalation
    • 4.1.3. Transdermal
    • 4.1.4. Injectable
    • 4.1.5. Ocular
    • 4.1.6. Nasal
    • 4.1.7. Topical
    • 4.1.8. Others
  • 4.2. RoA Market Share, 2024 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Drug Delivery Devices Market by RoA Outlook
  • 4.5. Market Size & Forecast and Trend Analysis, 2018 to 2030 for the following
    • 4.5.1. Oral
      • 4.5.1.1. Market estimates and forecast, by oral, 2018 to 2030 (Revenue, USD Billion)
    • 4.5.2. Inhalation
      • 4.5.2.1. Market estimates and forecast, by inhalation, 2018 to 2030 (Revenue, USD Billion)
    • 4.5.3. Transdermal
      • 4.5.3.1. Market estimates and forecast, by transdermal, 2018 to 2030 (Revenue, USD Billion)
    • 4.5.4. Injectable
      • 4.5.4.1. Market estimates and forecast, by injectable, 2018 to 2030 (Revenue, USD Billion)
    • 4.5.5. Ocular
      • 4.5.5.1. Market estimates and forecast, by ocular, 2018 to 2030 (Revenue, USD Billion)
    • 4.5.6. Nasal
      • 4.5.6.1. Market estimates and forecast, by nasal, 2018 to 2030 (Revenue, USD Billion)
    • 4.5.7. Topical
      • 4.5.7.1. Market estimates and forecast, by tropical, 2018 to 2030 (Revenue, USD Billion)
    • 4.5.8. Others
      • 4.5.8.1. Market estimates and forecast, by others, 2018 to 2030 (Revenue, USD Billion)

Chapter 5. Application Estimates & Trend Analysis

  • 5.1. Definition and Scope
    • 5.1.1. Oncology
    • 5.1.2. Infectious diseases
    • 5.1.3. Respiratory disease
    • 5.1.4. Diabetes
    • 5.1.5. Cardiovascular disease
    • 5.1.6. Autoimmune disease
    • 5.1.7. Central nervous system disorders
    • 5.1.8. Others
  • 5.2. Application Market Share, 2024 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Global Drug Delivery Devices Market by Application Outlook
  • 5.5. Market Size & Forecast and Trend Analysis, 2018 to 2030 for the following
    • 5.5.1. Oncology
      • 5.5.1.1. Market estimates and forecast, by oncology, 2018 to 2030 (Revenue, USD Billion)
    • 5.5.2. Infectious disease
      • 5.5.2.1. Market estimates and forecast, by infectious disease, 2018 to 2030 (Revenue, USD Billion)
    • 5.5.3. Respiratory disease
      • 5.5.3.1. Market estimates and forecast, by respiratory disease, 2018 to 2030 (Revenue, USD Billion)
    • 5.5.4. Diabetes
      • 5.5.4.1. Market estimates and forecast, by diabetes, 2018 to 2030 (Revenue, USD Billion)
    • 5.5.5. Cardiovascular diseases
      • 5.5.5.1. Market estimates and forecast, by cardiovascular diseases, 2018 to 2030 (Revenue, USD Billion)
    • 5.5.6. Autoimmune disease
      • 5.5.6.1. Market estimates and forecast, by autoimmune disease, 2018 to 2030 (Revenue, USD Billion)
    • 5.5.7. Central nervous system disorders
      • 5.5.7.1. Market estimates and forecast, by central nervous system disorders, 2018 to 2030 (Revenue, USD Billion)
    • 5.5.8. Others
      • 5.5.8.1. Market estimates and forecast, by others, 2018 to 2030 (Revenue, USD Billion)

Chapter 6. End-use Estimates & Trend Analysis

  • 6.1. Definition and Scope
    • 6.1.1. Hospitals
    • 6.1.2. Diagnostic centers
    • 6.1.3. Ambulatory surgery centers/clinics
    • 6.1.4. Home care settings
    • 6.1.5. Others
  • 6.2. End-use Market Share, 2023 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Global Drug Delivery Devices Market by End-use Outlook
  • 6.5. Market Size & Forecast and Trend Analysis, 2018 to 2030 for the following
    • 6.5.1. Hospital
      • 6.5.1.1. Market estimates and forecast, by hospital, 2018 to 2030 (Revenue, USD Billion)
    • 6.5.2. Diagnostic centers
      • 6.5.2.1. Market estimates and forecast, by diagnostic centers, 2018 to 2030 (Revenue, USD Billion)
    • 6.5.3. Ambulatory surgery centers/clinics
      • 6.5.3.1. Market estimates and forecast, by ambulatory surgery centers/clinics, 2018 to 2030 (Revenue, USD Billion)
    • 6.5.4. Home care settings
      • 6.5.4.1. Market estimates and forecast, by home care settings, 2018 to 2030 (Revenue, USD Billion)
    • 6.5.5. Others
      • 6.5.5.1. Market estimates and forecast, by others, 2018 to 2030 (Revenue, USD Billion)

Chapter 7. Drug Delivery Devices Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Regional Market Share and Leading Players, 2019
    • 7.4.1. North America
    • 7.4.2. Europe
    • 7.4.3. Asia Pacific
    • 7.4.4. Latin America
    • 7.4.5. Middle East & Africa
  • 7.5. SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
    • 7.5.1. North America
    • 7.5.2. Europe
    • 7.5.3. Asia Pacific
    • 7.5.4. Latin America
    • 7.5.5. Middle East & Africa
  • 7.6. Market Size & Forecast, Volume & Trend Analysis, 2018 to 2030
  • 7.7. North America
    • 7.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.7.2. U.S.
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Regulatory framework
      • 7.7.2.4. Reimbursement structure
      • 7.7.2.5. U.S. market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 7.7.3. Canada
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Regulatory framework
      • 7.7.3.4. Reimbursement structure
      • 7.7.3.5. Canada market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 7.8. Europe
    • 7.8.1. UK
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Competitive scenario
      • 7.8.1.3. Regulatory framework
      • 7.8.1.4. Reimbursement structure
      • 7.8.1.5. UK market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 7.8.2. Germany
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Competitive scenario
      • 7.8.2.3. Regulatory framework
      • 7.8.2.4. Reimbursement structure
      • 7.8.2.5. Germany market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 7.8.3. France
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Competitive scenario
      • 7.8.3.3. Regulatory framework
      • 7.8.3.4. Reimbursement structure
      • 7.8.3.5. France market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 7.8.4. Italy
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Competitive scenario
      • 7.8.4.3. Regulatory framework
      • 7.8.4.4. Reimbursement structure
      • 7.8.4.5. Italy market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 7.8.5. Spain
      • 7.8.5.1. Key country dynamics
      • 7.8.5.2. Competitive scenario
      • 7.8.5.3. Regulatory framework
      • 7.8.5.4. Reimbursement structure
      • 7.8.5.5. Spain market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 7.8.6. Denmark
      • 7.8.6.1. Key country dynamics
      • 7.8.6.2. Competitive scenario
      • 7.8.6.3. Regulatory framework
      • 7.8.6.4. Reimbursement structure
      • 7.8.6.5. Denmark market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 7.8.7. Sweden
      • 7.8.7.1. Key country dynamics
      • 7.8.7.2. Competitive scenario
      • 7.8.7.3. Regulatory framework
      • 7.8.7.4. Reimbursement structure
      • 7.8.7.5. Sweden market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 7.8.8. Norway
      • 7.8.8.1. Key country dynamics
      • 7.8.8.2. Competitive scenario
      • 7.8.8.3. Regulatory framework
      • 7.8.8.4. Reimbursement structure
      • 7.8.8.5. Norway market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 7.9. Asia Pacific
    • 7.9.1. Japan
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Competitive scenario
      • 7.9.1.3. Regulatory framework
      • 7.9.1.4. Reimbursement structure
      • 7.9.1.5. Japan market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 7.9.2. China
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Competitive scenario
      • 7.9.2.3. Regulatory framework
      • 7.9.2.4. Reimbursement structure
      • 7.9.2.5. China market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 7.9.3. India
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Competitive scenario
      • 7.9.3.3. Regulatory framework
      • 7.9.3.4. Reimbursement structure
      • 7.9.3.5. India market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 7.9.4. Australia
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Competitive scenario
      • 7.9.4.3. Regulatory framework
      • 7.9.4.4. Reimbursement structure
      • 7.9.4.5. Australia market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 7.9.5. South Korea
      • 7.9.5.1. Key country dynamics
      • 7.9.5.2. Competitive scenario
      • 7.9.5.3. Regulatory framework
      • 7.9.5.4. Reimbursement structure
      • 7.9.5.5. South Korea market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 7.9.6. Thailand
      • 7.9.6.1. Key country dynamics
      • 7.9.6.2. Competitive scenario
      • 7.9.6.3. Regulatory framework
      • 7.9.6.4. Reimbursement structure
      • 7.9.6.5. Thailand market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 7.10. Latin America
    • 7.10.1. Brazil
      • 7.10.1.1. Key country dynamics
      • 7.10.1.2. Competitive scenario
      • 7.10.1.3. Regulatory framework
      • 7.10.1.4. Reimbursement structure
      • 7.10.1.5. Brazil market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 7.10.2. Mexico
      • 7.10.2.1. Key country dynamics
      • 7.10.2.2. Competitive scenario
      • 7.10.2.3. Regulatory framework
      • 7.10.2.4. Reimbursement structure
      • 7.10.2.5. Mexico market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 7.10.3. Argentina
      • 7.10.3.1. Key country dynamics
      • 7.10.3.2. Competitive scenario
      • 7.10.3.3. Regulatory framework
      • 7.10.3.4. Reimbursement structure
      • 7.10.3.5. Argentina market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 7.11. MEA
    • 7.11.1. South Africa
      • 7.11.1.1. Key country dynamics
      • 7.11.1.2. Competitive scenario
      • 7.11.1.3. Regulatory framework
      • 7.11.1.4. Reimbursement structure
      • 7.11.1.5. South Africa market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 7.11.2. Saudi Arabia
      • 7.11.2.1. Key country dynamics
      • 7.11.2.2. Competitive scenario
      • 7.11.2.3. Regulatory framework
      • 7.11.2.4. Reimbursement structure
      • 7.11.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 7.11.3. UAE
      • 7.11.3.1. Key country dynamics
      • 7.11.3.2. Competitive scenario
      • 7.11.3.3. Regulatory framework
      • 7.11.3.4. Reimbursement structure
      • 7.11.3.5. UAE market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 7.11.4. Kuwait
      • 7.11.4.1. Key country dynamics
      • 7.11.4.2. Competitive scenario
      • 7.11.4.3. Regulatory framework
      • 7.11.4.4. Reimbursement structure
      • 7.11.4.5. Kuwait market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Innovators
    • 8.2.2. Market Lenders
    • 8.2.3. Emerging Players
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2023
  • 8.4. Public Companies
    • 8.4.1. Company market position analysis (Revenue, geographic, presence, product portfolio, key serviceable industries, key alliance
    • 8.4.2. Company market share/ranking, by region
    • 8.4.3. Competitive dashboard analysis
      • 8.4.3.1. Market differentiators
      • 8.4.3.2. Synergy analysis: major deals and strategic alliances
  • 8.5. Private Companies
    • 8.5.1. List of key emerging companies/technology disruptors/innovators
    • 8.5.2. Funding outlook
    • 8.5.3. Regional network map
    • 8.5.4. Company market position analysis (Geographic, presence, product portfolio, key alliance, industry experience)
  • 8.6. Suppliers Ranking
  • 8.7. Key Companies Profiled
    • 8.7.1. Pfizer, Inc,
      • 8.7.1.1. Company overview
      • 8.7.1.2. Financial performance
      • 8.7.1.3. Product benchmarking
      • 8.7.1.4. Strategic initiatives
    • 8.7.2. F. Hoffmann-La Roche Ltd.
      • 8.7.2.1. Company overview
      • 8.7.2.2. Financial performance
      • 8.7.2.3. Product benchmarking
      • 8.7.2.4. Strategic initiatives
    • 8.7.3. Johnson and Johnson Services
      • 8.7.3.1. Company overview
      • 8.7.3.2. Financial performance
      • 8.7.3.3. Product benchmarking
      • 8.7.3.4. Strategic initiatives
    • 8.7.4. Novartis AG
      • 8.7.4.1. Company overview
      • 8.7.4.2. Financial performance
      • 8.7.4.3. Product benchmarking
      • 8.7.4.4. Strategic initiatives
    • 8.7.5. Bayer AG
      • 8.7.5.1. Company overview
      • 8.7.5.2. Financial performance
      • 8.7.5.3. Product benchmarking
      • 8.7.5.4. Strategic initiatives
    • 8.7.6. BD
      • 8.7.6.1. Company overview
      • 8.7.6.2. Financial performance
      • 8.7.6.3. Product benchmarking
      • 8.7.6.4. Strategic initiatives
    • 8.7.7. Uniqure N.V.
      • 8.7.7.1. Company overview
      • 8.7.7.2. Financial performance
      • 8.7.7.3. Product benchmarking
      • 8.7.7.4. Strategic initiatives
    • 8.7.8. SiBiono GeneTech Co.
      • 8.7.8.1. Company overview
      • 8.7.8.2. Financial performance
      • 8.7.8.3. Product benchmarking
      • 8.7.8.4. Strategic initiatives
    • 8.7.9. Shanghai Sunway Biotech Co., Ltd
      • 8.7.9.1. Company overview
      • 8.7.9.2. Financial performance
      • 8.7.9.3. Product benchmarking
      • 8.7.9.4. Strategic initiatives
    • 8.7.10. Human Stem Cells Institute
      • 8.7.10.1. Company overview
      • 8.7.10.2. Financial performance
      • 8.7.10.3. Product benchmarking
      • 8.7.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America drug delivery devices market, by country, 2018 - 2030 (USD Billion)
  • Table 3 North America drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 4 North America drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 5 North America drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 6 U.S. drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 7 U.S. drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 8 U.S. drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 9 Canada drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 10 Canada drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 11 Canada drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 12 Europe drug delivery devices market, by region, 2018 - 2030 (USD Billion)
  • Table 13 Europe drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 14 Europe drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 15 Europe drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 16 Germany drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 17 Germany drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 18 Germany drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 19 U.K. drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 20 U.K. drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 21 U.K. drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 22 France drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 23 France drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 24 France drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 25 Italy drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 26 Italy drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 27 Italy drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 28 Spain drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 29 Spain drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 30 Spain drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 31 Denmark drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 32 Denmark drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 33 Denmark drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 34 Sweden drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 35 Sweden drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 36 Sweden drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 37 Norway drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 38 Norway drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 39 Norway drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 40 APAC drug delivery devices market, by region, 2018 - 2030 (USD Billion)
  • Table 41 APAC drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 42 APAC drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 43 APAC drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 44 China drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 45 China drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 46 China drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 47 Japan drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 48 Japan drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 49 Japan drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 50 India drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 51 India drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 52 India drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 53 Thailand drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 54 Thailand drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 55 Thailand drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 56 South Korea drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 57 South Korea drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 58 South Korea drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 59 Australia drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 60 Australia drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 61 Australia drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 62 Latin America drug delivery devices market, by region, 2018 - 2030 (USD Billion)
  • Table 63 Latin America drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 64 Latin America drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 65 Latin America drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 66 Brazil drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 67 Brazil drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 68 Brazil drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 69 Mexico drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 70 Mexico drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 71 Mexico drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 72 Argentina drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 73 Argentina drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 74 Argentina drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 75 Middle East and Africa drug delivery devices market, by region, 2018 - 2030 (USD Billion)
  • Table 76 Middle East and Africa drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 77 Middle East and Africa drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 78 Middle East and Africa drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 79 South Africa drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 80 South Africa drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 81 South Africa drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 82 Saudi Arabia drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 83 Saudi Arabia drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 84 Saudi Arabia drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 85 UAE drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 86 UAE drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 87 UAE drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 88 Kuwait drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 89 Kuwait drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 90 Kuwait drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Drug delivery devices: market outlook
  • Fig. 14 Drug delivery devices market competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook.
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Drug delivery devices market driver impact
  • Fig. 20 Drug delivery devices market restraint impact
  • Fig. 21 Drug delivery devices market strategic initiatives analysis
  • Fig. 22 Drug delivery devices market: RoA movement analysis
  • Fig. 23 Drug delivery devices market: RoA outlook and key takeaways
  • Fig. 24 Oral market estimates and forecast, 2018 - 2030
  • Fig. 25 Inhalation market estimates and forecast, 2018 - 2030
  • Fig. 26 Transdermal market estimates and forecast, 2018 - 2030
  • Fig. 27 Injectable market estimates and forecast, 2018 - 2030
  • Fig. 28 Ocular market estimates and forecast, 2018 - 2030
  • Fig. 29 Nasal market estimates and forecast, 2018 - 2030
  • Fig. 30 Topical market estimates and forecast, 2018 - 2030
  • Fig. 31 Others market estimates and forecast, 2018 - 2030
  • Fig. 32 Drug delivery devices market: application movement analysis
  • Fig. 33 Drug delivery devices market: application outlook and key takeaways
  • Fig. 34 Oncology market estimates and forecast, 2018 - 2030
  • Fig. 35 Infectious diseases estimates and forecast, 2018 - 2030
  • Fig. 36 Respiratory diseases estimates and forecast, 2018 - 2030
  • Fig. 37 Diabetes estimates and forecast, 2018 - 2030
  • Fig. 38 Cardiovascular diseases estimates and forecast, 2018 - 2030
  • Fig. 39 Autoimmune diseases estimates and forecast, 2018 - 2030
  • Fig. 40 Central nervous system disorders estimates and forecast, 2018 - 2030
  • Fig. 41 Others estimates and forecast, 2018 - 2030
  • Fig. 42 Drug delivery devices market: end-use movement analysis
  • Fig. 43 Drug delivery devices market: End-use outlook and key takeaways
  • Fig. 44 Hospitals estimates and forecast, 2018 - 2030
  • Fig. 45 Diagnostic centers estimates and forecast, 2018 - 2030
  • Fig. 46 Ambulatory surgery centers/clinics estimates and forecast, 2018 - 2030
  • Fig. 47 Home care setting estimates and forecast, 2018 - 2030
  • Fig. 48 Others estimates and forecast, 2018 - 2030
  • Fig. 49 Global drug delivery devices market: regional movement analysis
  • Fig. 50 Global drug delivery market: regional outlook and key takeaways
  • Fig. 51 Global market share and leading players
  • Fig. 52 North America market share and leading players
  • Fig. 53 Europe market share and leading players
  • Fig. 54 Asia Pacific market share and leading players
  • Fig. 55 Latin America market share and leading players
  • Fig. 56 Middle East & Africa market share and leading players
  • Fig. 57 North America: SWOT
  • Fig. 58 Europe SWOT
  • Fig. 59 Asia Pacific SWOT
  • Fig. 60 Latin America SWOT
  • Fig. 61 MEA SWOT
  • Fig. 62 North America, by country
  • Fig. 63 North America
  • Fig. 64 North America market estimates and forecast, 2018 - 2030
  • Fig. 65 U.S.
  • Fig. 66 U.S. market estimates and forecast, 2018 - 2030
  • Fig. 67 Canada
  • Fig. 68 Canada market estimates and forecast, 2018 - 2030
  • Fig. 69 Europe
  • Fig. 70 Europe. market estimates and forecast, 2018 - 2030
  • Fig. 71 UK
  • Fig. 72 UK market estimates and forecast, 2018 - 2030
  • Fig. 73 Germany
  • Fig. 74 Germany market estimates and forecast, 2018 - 2030
  • Fig. 75 France
  • Fig. 76 France market estimates and forecast, 2018 - 2030
  • Fig. 77 Italy
  • Fig. 78 Italy market estimates and forecast, 2018 - 2030
  • Fig. 79 Spain
  • Fig. 80 Spain market estimates and forecast, 2018 - 2030
  • Fig. 81 Denmark
  • Fig. 82 Denmark market estimates and forecast, 2018 - 2030
  • Fig. 83 Sweden
  • Fig. 84 Sweden market estimates and forecast, 2018 - 2030
  • Fig. 85 Norway
  • Fig. 86 Norway market estimates and forecast, 2018 - 2030
  • Fig. 87 Asia Pacific
  • Fig. 88 Asia Pacific market estimates and forecast, 2018 - 2030
  • Fig. 89 China
  • Fig. 90 China market estimates and forecast, 2018 - 2030
  • Fig. 91 Japan
  • Fig. 92 Japan market estimates and forecast, 2018 - 2030
  • Fig. 93 India
  • Fig. 94 India market estimates and forecast, 2018 - 2030
  • Fig. 95 Thailand
  • Fig. 96 Thailand. market estimates and forecast, 2018 - 2030
  • Fig. 97 South Korea
  • Fig. 98 South Korea market estimates and forecast, 2018 - 2030
  • Fig. 99 Australia
  • Fig. 100 Australia market estimates and forecast, 2018 - 2030
  • Fig. 101 Latin America
  • Fig. 102 Latin America market estimates and forecast, 2018 - 2030
  • Fig. 103 Brazil
  • Fig. 104 Brazil market estimates and forecast, 2018 - 2030
  • Fig. 105 Mexico
  • Fig. 106 Mexico market estimates and forecast, 2018 - 2030
  • Fig. 107 Argentina
  • Fig. 108 Argentina market estimates and forecast, 2018 - 2030
  • Fig. 109 Middle East and Africa
  • Fig. 110 Middle East and Africa. market estimates and forecast, 2018 - 2030
  • Fig. 111 South Africa
  • Fig. 112 South Africa market estimates and forecast, 2018 - 2030
  • Fig. 113 Saudi Arabia
  • Fig. 114 Saudi Arabia market estimates and forecast, 2018 - 2030
  • Fig. 115 UAE
  • Fig. 116 UAE market estimates and forecast, 2018 - 2030
  • Fig. 117 Kuwait
  • Fig. 118 Kuwait market estimates and forecast, 2018 - 2030
  • Fig. 119 Participant categorization- drug delivery devices market
  • Fig. 120 Market share of key market players- drug delivery devices market